- Estimating the Cost Saving Due to the Effect of Kremezin in Delaying the Initiation of Dialysis Treatments among Patients with Chronic Renal Failure
-
Kang HY, Cho W, Lee S, Kim HJ, Lee HY, Woo TW
- KMID: 792402
- J Prev Med Public Health.
- 2006 Mar;39(2):149-158.
OBJECTIVES: We wanted to evaluate the economic value of a pharmaceutical product, Kremezin, for treating patients with chronic renal failure (CRF) by estimating the amount of cost savings due... -
- CITED
-
- Close
- SHARE
-
- Close
